Soleno Therapeutics Inc (SLNO)

Investing Cash Flow

$37.98M

Quarterly · Period ending: · USD

SLNO logo

SLNO Investing Cash Flow

Latest reported$37.98M
SLNO Quarterly Cash from Investing (-$1.27K → $37.98M)
High-resolution chart · PNG

SLNO investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
37,983,000
-125,360,000
-91,443,000
-7,915,000
22,937,000
6,443,000
4,040,000
-120,921,000
-115,244,000
0
0
0
0
-6,000
-7,000
-7,000
0
-13,000
-5,000
0
-4,000
-4,000
-3,000
0
0
103,000
441,000
-6,000
-10,000
-174,000
-5,000
-1,000
0
239,782
371,000
-228,000
-4,000
320
0
-20,000
-19,000
-31,777
-1,258,000
-30,000
-1,000
-30,683
4,074
-4,074
4,000
-274
-1,000
1,274
-1,274
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.